Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. Valero is active.

Publication


Featured researches published by A. Valero.


Allergy | 2017

Pilot study of mobile phone technology in allergic rhinitis in European countries. The MASK-rhinitis study.

Jean Bousquet; D. Caimmi; A. Bedbrook; M. Bewick; Peter Hellings; Philippe Devillier; S. Arnavielhe; Claus Bachert; K. C. Bergmann; G. W. Canonica; N. H. Chavannes; A. A. Cruz; Ronald Dahl; Pascal Demoly; G. De Vries; E. Mathieu-Dupas; A. Finkwagner; João Fonseca; N. Guldemond; T. Haahtela; B. Hellqvist-Dahl; J Just; Thomas Keil; L. Klimek; M. L. Kowalski; Mikael Kuitunen; Piotr Kuna; V. Kvedariene; D. Laune; Ana Margarida Pereira

The use of Apps running on smartphones and tablets profoundly affects medicine. The MASK‐rhinitis (MACVIA‐ARIA Sentinel NetworK for allergic rhinitis) App (Allergy Diary) assesses allergic rhinitis symptoms, disease control and impact on patients’ lives. It is freely available in 20 countries (iOS and Android platforms).


Allergy | 2017

Work productivity in rhinitis using cell phones: The MASK pilot study.

Jean Bousquet; M. Bewick; S. Arnavielhe; E. Mathieu-Dupas; R. Murray; A. Bedbrook; D. Caimmi; O. Vandenplas; Peter Hellings; Claus Bachert; J. M. Anto; K. C. Bergmann; Carsten Bindslev-Jensen; Sinthia Bosnic-Anticevich; J. Bouchard; G. W. Canonica; N. H. Chavannes; A. A. Cruz; Ronald Dahl; Pascal Demoly; G. De Vries; Philippe Devillier; A. Finkwagner; W. J. Fokkens; João Fonseca; N. Guldemond; T. Haahtela; B. Hellqvist-Dahl; J Just; Thomas Keil

Allergic rhinitis often impairs social life and performance. The aim of this cross‐sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS‐global measured), nasal (VAS‐nasal), ocular (VAS‐ocular) and asthma symptoms (VAS‐asthma) as well as work (VAS‐work). A combined nasal‐ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI:AS) in six EU countries. All consecutive users who completed the VAS‐work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS‐work. Symptoms of allergic rhinitis were controlled (VAS‐global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS‐work >50). There was a significant correlation between VAS‐global calculated and VAS‐work (Rho=0.83, P<0.00001, Spearmans rank test). In 144 users, there was a significant correlation between VAS‐work and WPAI:AS (Rho=0.53, P<0.0001). This pilot study provides not only proof‐of‐concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms.


Clinical and Translational Allergy | 2017

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: A SUNFRAIL report

Jean Bousquet; G. L. Onorato; Claus Bachert; M. Barbolini; A. Bedbrook; Leif Bjermer; J. Correia de Sousa; N. H. Chavannes; A. A. Cruz; E. de Manuel Keenoy; Philippe Devillier; João Fonseca; S. Hun; T. Kostka; Peter Hellings; M. Illario; J. C. Ivancevich; Désirée Larenas-Linnemann; J Millot-Keurinck; Dermot Ryan; B. Samolinski; Aziz Sheikh; Arzu Yorgancioglu; I. Agache; S. Arnavielhe; M. Bewick; I. Annesi-Maesano; J. M. Anto; K. C. Bergmann; Carsten Bindslev-Jensen

A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of axa0Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, allxa0members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.


Allergy | 2018

Treatment of allergic rhinitis using mobile technology with real world data: The MASK observational pilot study

Jean Bousquet; S. Arnavielhe; A. Bedbrook; G Alexis-Alexandre; M. van Eerd; R. Murray; G. W. Canonica; M. Illario; Enrica Menditto; G. Passalacqua; Cristiana Stellato; Massimo Triggiani; P. Carreiro-Martins; João Fonseca; M Morais Almeida; Luís Nogueira-Silva; Ana Margarida Pereira; A. Todo Bom; I. Bosse; D. Caimmi; Pascal Demoly; Philippe Devillier; J. F. Fontaine; J Just; G. L. Onorato; M. L. Kowalski; Piotr Kuna; B. Samolinski; J. M. Anto; J. Mullol

Large observational implementation studies are needed to triangulate the findings from randomized control trials as they reflect “real‐world” everyday practice. In a pilot study, we attempted to provide additional and complementary insights on the real‐life treatment of allergic rhinitis (AR) using mobile technology.


Journal of Investigational Allergology and Clinical Immunology | 2017

Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire using Mobile Technology: The MASK study.

Jean Bousquet; O. Vandenplas; M. Bewick; S. Arnavielhe; A. Bedbrook; Ruth Murray; M. van Eerd; João Fonseca; Mário Morais-Almeida; A. Todo Bom; A. A. Cruz; F. Sarquis Serpa; J. da Silva; E. Menditto; G. Passalacqua; C. Stellato; M. T. Ventura; D. Caimmi; Pascal Demoly; K. C. Bergmann; Thomas Keil; L. Klimek; Ralph Mösges; S. Shamai; T. Zuberbier; Désirée Larenas-Linnemann; M. Rodriguez Gonzalez; M. T. Burguete Cabañas; Dermot Ryan; Aziz Sheikh

J Bousquet, MD , O VandenPlas, MD , M Bewick, MD , S Arnavielhe, PhD , A Bedbrook, BSc , R Murray, PhD , M van Eerd, MSc , J Fonseca, MD , M Morais-Almeida, MD , A Todo Bom, MD , AA Cruz, MD , F Sarquis Serpa, MD, 12 J da Silva, MD, 13 E Menditto, PhD, , G Passalacqua, MD , C Stellato , MD, 16 , MT Ventura, MD , D Caimmi, MD , P Demoly, MD , KC Bergmann, MD , T Keil, MD , L Klimek, MD , R Mösges, MD , S Shamai, MD, 22 T Zuberbier, MD , D Larenas-Linnemann, MD , M Rodriguez Gonzalez, MD, 24 MT Burguete Cabañas, MD, 25 D Ryan, MD , A Sheikh, MD , JM Anto, MD , J Mullol, MD , A Valero, MD 29 ML Kowalski, MD , P Kuna, MD , B Samolinski, MD , PV Tomazic, MD , S Bosnic-Anticevich, PhD , RE OHehir MD, , G De Vries, MSc , D Laune, PhD 5


Allergy | 2018

Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study.

Jean Bousquet; Philippe Devillier; Josep M. Antó; M. Bewick; Tari Haahtela; S. Arnavielhe; A. Bedbrook; Ruth Murray; M. van Eerd; João Fonseca; M Morais Almeida; A. Todo Bom; Enrica Menditto; G. Passalacqua; Cristiana Stellato; Massimo Triggiani; M. T. Ventura; G. Vezzani; I. Annesi-Maesano; R. Bourret; I. Bosse; D. Caimmi; C. Cartier; Pascal Demoly; Jocelyne Just; F. Portejoie; Valérie Siroux; F. Viart; K. C. Bergmann; Thomas Keil

Multimorbidity in allergic airway diseases is well known, but no data exist about the daily dynamics of symptoms and their impact on work. To better understand this, we aimed to assess the presence and control of daily allergic multimorbidity (asthma, conjunctivitis, rhinitis) and its impact on work productivity using a mobile technology, the Allergy Diary.

Collaboration


Dive into the A. Valero's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. Caimmi

University of Montpellier

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. A. Cruz

Federal University of Bahia

View shared research outputs
Top Co-Authors

Avatar

J Just

University of Paris

View shared research outputs
Top Co-Authors

Avatar

J. M. Anto

Pompeu Fabra University

View shared research outputs
Researchain Logo
Decentralizing Knowledge